[1] |
Zhang Yu, Gao Yingxia, Gu Ningyan, Zhu Hong, Chen Jingjing, Hu Qingjie, Zhou Min, Duan Yuanyuan, Yao Xu.
Clinical efficacy and safety of omalizumab in the treatment of chronic spontaneous urticaria
[J]. Chinese Journal of Dermatology, 2021, 54(7): 582-585.
|
[2] |
Liang Gaopeng, Song Zhiqiang.
Role of immunoglobulin E autoantibodies in autoimmune skin diseases
[J]. Chinese Journal of Dermatology, 2021, 54(6): 553-556.
|
[3] |
Liu Xin, Liu Nian, Chen Hongxiang.
Diagnosis and treatment of contact urticaria
[J]. Chinese Journal of Dermatology, 2021, 54(12): 1114-1117.
|
[4] |
Yu Miao, Chen Yudi, Liu Bo, Song Xiaoting, Liao Shuanglu, Luan Tingting, Zhao Zuotao.
Scoring systems for chronic spontaneous urticaria in clinical research and practice
[J]. Chinese Journal of Dermatology, 2021, 54(12): 1117-1121.
|
[5] |
Yan Huimin, Du Xiao, Meng Linghe, Weng Lishuo, Zeng Sanwu.
Analysis of differences in gut microbiota in patients with chronic spontaneous urticaria by 16S rRNA high-throughput sequencing
[J]. Chinese Journal of Dermatology, 2021, 54(12): 1071-1076.
|
[6] |
Song Xiaoting, Liu Bo, Chen Yudi, Yu Miao, Liao Shuanglu, Luan Tingting, Zhao Zuotao.
Efficacy and safety of omalizumab for treatment of chronic spontaneous urticaria
[J]. Chinese Journal of Dermatology, 2021, 54(12): 1063-1070.
|
[7] |
Zhao Zuotao.
Diagnosis and treatment of chronic urticaria: current status and future prospects
[J]. Chinese Journal of Dermatology, 2021, 54(12): 1105-1109.
|
[8] |
Chen Qiquan, Song Zhiqiang.
Treatment of chronic inducible urticaria
[J]. Chinese Journal of Dermatology, 2021, 54(12): 1110-1113.
|
[9] |
Centre for Urticaria Research, Chinese Society of Dermatology.
Consensus on management of chronic urticaria using anti-immunoglobulin E therapy (omalizumab)
[J]. Chinese Journal of Dermatology, 2021, 54(12): 1057-1062.
|
[10] |
Gao Meng, Jiang Yiqun.
Cutaneous manifestations of COVID-19
[J]. Chinese Journal of Dermatology, 2021, 0(1): 20200509-e20200509.
|
[11] |
Jiao Qingqing, Zhang Xiaoyan, Ji Jiang.
Biological indicators related to disease activity of chronic spontaneous urticaria: an update
[J]. Chinese Journal of Dermatology, 2021, 0(1): 20201158-e20201158.
|
[12] |
Miao YU Yu-Di CHEN Bo Liu Xiao-Ting SONG Zuotao.
The Chinese version of the Urticaria Control Test and validation of its reliability and validity
[J]. Chinese Journal of Dermatology, 2020, 53(7): 533-538.
|
[13] |
Li Yan, Xu Wei, Gu Heng, Ju Mei, Duan Yiqun, Zeng Xianyu, Diao Qingchun, Ning Chunzhu, Li Linfeng.
Acrivastine combined with loratadine in the treatment of chronic refractory urticaria: a multicenter, randomized controlled study
[J]. Chinese Journal of Dermatology, 2020, 53(5): 319-323.
|
[14] |
Chen Yudi, Liu Bo, Song Xiaoting, Zhao Zuotao.
Clinical application of critical temperature threshold measurement in cold contact urticaria
[J]. Chinese Journal of Dermatology, 2020, 53(5): 352-355.
|
[15] |
Yu Miao, Chen Yudi, Liu Bo, Song Xiaoting, Zhao Zuotao.
The Chinese version of chronic urticaria quality of life questionnaire (CU-Q2oL): validation of reliability and validity
[J]. Chinese Journal of Dermatology, 2020, 53(12): 992-997.
|